Cell Therapy Supply Chain Logistics Associate

Cell Therapy Supply Chain Logistics Associate

Nexcella, Inc.

Sao Paulo / Hybrid

Our 3 Core Values

• Intelligence
• Integrity
• Initiative

What You'll Do

Overseeing the patient journey from screening through treatment across CAR-T therapies You will work cross-functionally with internal and external stakeholders to ensure therapies reach patients as quickly and efficiently as possible.

Key Responsibilities

You will play a key role in supporting our Global Patient Supply Operations :

Qualifications

About Nexcella, Inc.

Nexcella, Inc. is a subsidiary of Immix Biopharma, Inc. (ImmixBio) (Nasdaq : IMMX), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a “digital filter” that filters out non-specific activation. NXC-201 is being evaluated in the U.S. multi-center study for relapsed / refractory AL Amyloidosis NEXICART-2 (NCT06097832), with a registrational design. Interim results were presented at ASCO 2025 in an oral presentation by Heather Landau, M.D. of Memorial Sloan Kettering Cancer Center. NXC-201 has been awarded Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA. Learn more at and